The prognostic significance of epidermal growth factor receptor (EGFR) expression in lung
cancer and, more importantly, its ability to predict response to anti-EGFR therapies, are …

… that target the epidermal growth factor receptor (EGFR) provide important insights for new
lung cancer therapies, as well as for the broader field of targeted cancer therapies. We review …

… –small-cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors (TKIs) have demonstrated significantly improved tumor responses and progression-…

… in the epidermal growth factor receptor gene (EGFR) confer hypersensitivity to the tyrosine
kinase inhibitors gefitinib and erlotinib in patients with advanced non–small-cell lung cancer. …

… downstream targets is thought to yield more aggressive tumor phenotypes. Mutations in
epidermal growth factor receptor have been discovered in association with some lung cancers. …

… , particularly overexpression of epidermal growth factor receptor (EGFR) family proteins. …
EGF and transforming growth factor alpha. Epidermal growth factor receptor overexpression is …

… In the current review, we propose to illustrate the role of EGFR group of growth factors in lung
cancer progression and metastasis. We will particularly emphasize upon the impact of well-…

… They were stained for epidermal growth factor receptor (EGFr) by means of an indirect …
growth factor receptor may play a part in the genesis or spread of lung cancers. This is the …

… growth factor receptor (EGFR) mutations occur in lung adenocarcinoma, and even rare cases
of other subtypes with this mutation, such as adenosquamous cell carcinoma… lung cancers (…

… apoptosis, are in clinical development to treat lung cancer. Among these targeted
therapies are the oral, small-molecule epidermal growth factor receptor-tyrosine kinase (EGFR-TK) …